CATARACT SURGERY IN CHALLENGING CASES: Choosing the miLOOP for safe and effective energy-free fragmentation of a brunescent lens

News
Article

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Content
Evaluating the clinical performance of ZEISS AT ELANA and the new ’ELISA’* approach

Evaluating the clinical performance of ZEISS AT ELANA and the new ’ELISA’* approach

Joong Hun Kim, MD
August 19th 2025
Article
The ZEISS IOL Power Calculation Service. Providing guidance in complex cases

The ZEISS IOL Power Calculation Service. Providing guidance in complex cases

Patricia Casaer, MD ;Tobias Gutzeit, BSc
August 19th 2025
Article
My first experiences with AT ELANA 841P and ARTEVO 850

My first experiences with AT ELANA 841P and ARTEVO 850

Liem Trinh, MD
August 19th 2025
Article
Onboarding a new trifocal hydrophobic C-loop IOL My early experiences with AT ELANA® 841P from ZEISS

Onboarding a new trifocal hydrophobic C-loop IOL My early experiences with AT ELANA® 841P from ZEISS

Luis Fernández-Vega Cueto-Felgueroso, MD, PhD
August 19th 2025
Article
Upgrading cataract surgery skills – Unlocking the full potential of surgical video review using an AI-based application

Upgrading cataract surgery skills – Unlocking the full potential of surgical video review using an AI-based application

Supriya Samak Sriganesh, MD
August 19th 2025
Article
Providing spectacle independence for a young adult patient with cataract and astigmatism

Providing spectacle independence for a young adult patient with cataract and astigmatism

Nick Kopsachilis, MD, PhD
August 19th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.